AgingRePer-AGENCT07727369
RePer-AGE: Reorganization of Visuo-cognitive Functions Based on Peripheral Vision With Aging
A study testing Psychophysical visual recognition tasks, Ophthalmological assessment and Functional magnetic resonance imaging (fMRI) in people with Aging and Visual Perception, run by University Hospital, Grenoble at 1 site in France.
Trial summary
The RePer-AGE study investigates how central and peripheral vision contribute to visual recognition and how these mechanisms change with normal aging. The study is based on the hypothesis that peripheral vision provides rapid global information that supports visual recognition through predictive mechanisms. Read more about this study
- Who is it for?
- Ages 18 to 85 yearsHealthy volunteers can take part
- Conditions the study is for
- Aging, Visual Perception, Cognition
- What is being tested?
- Psychophysical visual recognition tasks, Ophthalmological assessment and Functional magnetic resonance imaging (fMRI)
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 160 participants
- Where
- 1 siteFrance
- Study dates
- 1 Sep 2026to Sep 2030
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 85 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Healthy young adults aged 18 to 30 years or healthy older adults aged 60 to 85 years.
- Normal or corrected-to-normal visual acuity.
- No ophthalmological disease affecting visual function.
- For participants aged 60 years or older: Mini-Mental State Examination (MMSE) score ≥23.
- Affiliated with a national health insurance system.
- Written informed consent.
Show all 12Show fewer
- Non inclusion Criteria:
- Individuals protected under French regulations governing research involving human participants.
- Employees or individuals under the direct authority of the investigators.
- History of neurological or psychiatric disorders likely to affect visual or cognitive functions.
- Current treatment likely to alter visual function or vigilance.
- MRI contraindications (metallic implants, pacemaker, severe claustrophobia, or other MRI safety contraindications) for participation in the MRI arm only.
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site
CHU Grenoble Alpes
Grenoble, Isère, 38043
Carole Peyrin, PhD, 0033615351350, carole.peyrin@univ-grenoble-alpes.fr
Mathilde Gallice, MD, 0033476767575, MGallice@chu-grenoble.fr
About this study
The RePer-AGE study investigates how central and peripheral vision contribute to visual recognition and how these mechanisms change with normal aging. The study is based on the hypothesis that peripheral vision provides rapid global information that supports visual recognition through predictive mechanisms. Healthy young adults (18-30 years) and older adults (60-85 years) will undergo visual psychophysical testing, ophthalmological examinations, and, for a subset of participants, functional magnetic resonance imaging (fMRI). The results are expected to improve our understanding of age-related changes in visuo-cognitive functions and provide reference data for future studies on age-related visual disorders.
Read the detailed description
Visual recognition depends on the complementary contribution of central and peripheral vision. Central vision provides high spatial resolution and supports the detailed analysis required for object identification, whereas peripheral vision rapidly extracts coarse visual information that provides a global representation of the surrounding environment. According to predictive models of visual processing, this early peripheral information is used to generate predictions that facilitate the subsequent processing of detailed visual inputs.
The RePer-AGE project is based on the hypothesis that peripheral vision plays a key role in predictive visual processing and that this contribution changes during normal aging. Although aging is associated with well-documented declines in visual acuity and contrast sensitivity, particularly for high spatial frequencies, several findings suggest that the processing of coarse visual information conveyed by peripheral vision may be relatively preserved. This preserved processing may contribute to compensatory mechanisms supporting visual recognition in older adults.
RePer-AGE is a prospective, monocentric interventional study conducted at Grenoble Alpes University Hospital (CHU Grenoble Alpes) and the Laboratoire de Psychologie et NeuroCognition (LPNC, CNRS, Université Grenoble Alpes). The study will recruit 160 healthy volunteers divided into two age groups: young adults (18-30 years) and older adults (60-85 years). Participants will undergo an ophthalmological examination to ensure normal or corrected-to-normal vision and the absence of ocular disease likely to affect visual performance. Older participants will also complete a brief cognitive screening assessment.
The project combines complementary behavioral, ophthalmological, and neuroimaging approaches to investigate the respective contributions of central and peripheral vision to visual recognition.
The first research axis combines psychophysical experiments with ophthalmological assessments. Participants perform computerized visual recognition tasks specifically designed to evaluate the relative contribution of central and peripheral vision. Additional ophthalmological examinations include automated static perimetry to assess retinal sensitivity across the visual field and low-luminance visual acuity testing. These measurements will allow the relationship between retinal function and visual recognition performance to be investigated.
The second research axis combines psychophysical experiments with functional magnetic resonance imaging (fMRI). During MRI acquisition, participants perform visual recognition tasks while blood oxygen level-dependent (BOLD) activity is recorded. These data will be used to identify the cortical networks supporting predictive visual processing and to determine how these neural mechanisms are modified during normal aging.
The psychophysical paradigms are derived from previous studies conducted by the research team and investigate two complementary aspects of visual recognition. One paradigm evaluates the respective contribution of central and peripheral vision to scene categorization, whereas the second examines how semantic information extracted from peripheral vision influences the recognition of centrally presented visual stimuli through predictive mechanisms.
The primary objective of the study is to determine how central and peripheral vision differentially contribute to visual recognition and how these mechanisms are reorganized with aging. Secondary objectives include characterizing age-related changes in retinal sensitivity, examining the relationship between retinal function and behavioral performance, and identifying the neural correlates of predictive visual processing using functional MRI.
The results of RePer-AGE are expected to improve the understanding of the mechanisms underlying normal visual aging. They will provide normative reference data for future studies investigating pathological aging and visual disorders affecting central vision, and may ultimately contribute to the development of new approaches for visual assessment and rehabilitation.
- Conditions
- Aging, Visual Perception, Cognition
- Being tested
- Psychophysical visual recognition tasks, Ophthalmological assessment, Functional magnetic resonance imaging (fMRI)
- Keywords
- Healthy Aging, Peripheral vision, Central vision, Visual recognition, Predictive processing, Psychophysics, Retinal sensitivity, fMRI
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Psychophysical visual recognition tasksBehavioural
Computerized visual recognition tasks assessing the respective contributions of central and peripheral vision to scene recognition and predictive visual processing.
Ophthalmological assessmentDiagnostic test
Ophthalmological examinations including retinal sensitivity (Humphrey automated perimetry) and low-luminance visual acuity.
Functional magnetic resonance imaging (fMRI)Diagnostic test
Functional MRI performed during psychophysical visual recognition tasks to assess brain activity associated with visual recognition and predictive visual processing.
| Study group | Role | What they receive |
|---|---|---|
| Psychophysics and Ophthalmology | Experimental | Participants undergo psychophysical visual recognition tasks together with ophthalmological examinations, including retinal sensitivity assessment by automated perimetry and low-luminance visual acuity testing. Receives: Behavioral: Psychophysical visual recognition tasks; Diagnostic Test: Ophthalmological assessment |
| Psychophysics and Functional MRI | Experimental | Participants undergo psychophysical visual recognition tasks while functional magnetic resonance imaging (fMRI) is performed to investigate the neural mechanisms underlying visual recognition and predictive processing. Receives: Behavioral: Psychophysical visual recognition tasks; Diagnostic Test: Functional magnetic resonance imaging (fMRI) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Behavioral performance during scene categorization tasks
Behavioral performance will be assessed using accuracy and response time during computerized scene categorization tasks evaluating (1) central versus peripheral vision (EXC paradigm) and (2) semantic congruency between peripheral and central vision (VPC paradigm). Comparisons will be performed between young and older adults.
Measured: Baseline (single experimental session)
Secondary outcomes (2)
Retinal sensitivity
Retinal sensitivity measured by Humphrey 30-2 automated perimetry, including Mean Deviation (MD), Pattern Standard Deviation (PSD), and retinal sensitivity thresholds.
Measured: Baseline
Brain activation during visual recognition
Blood oxygen level-dependent (BOLD) activity measured by functional magnetic resonance imaging during scene categorization tasks, including whole-brain analyses and regions of interest involved in visual recognition and predictive processing.
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Jul 2026
- Study start1 Sep 2026 (estimated)
- Primary completionMar 2030 (estimated)
- Study completionSep 2030 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for AgingStudies of the same condition, open and under way.
- More trials run by University Hospital, GrenobleThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants are assigned to one of two experimental arms according to the study procedures (psychophysics with ophthalmology or psychophysics with functional MRI). Both young and older adults are included in each arm.
- Masking
- None (open label)
- Enrolment
- 160 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Grenoble
- Sponsor type
- University, hospital or other
- Collaborators
- Centre National de la Recherche Scientifique, France, University Grenoble Alps, National Research Agency, France
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07727369
- Sponsor's protocol ID
- 38RC25.0395
- Other IDs
- ANR-25-CE28-6333, 2026-A00492-49
- Acronym
- RePer-AGE
- Status last verified
- Jul 2026
- First submitted
- 21 Jul 2026
- Last updated
- 27 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: De-identified individual participant data necessary to reproduce the results reported in scientific publications will be shared. Data may include demographic, behavioral, ophthalmological, and neuroimaging data after anonymization, in accordance with the study Data Management Plan and applicable data protection regulations.
Publications
Faurite C, Aprile E, Kauffmann L, Mermillod M, Gallice M, Chiquet C, Cottereau BR, Peyrin C. Interaction between central and peripheral vision: Influence of distance and spatial frequencies. J Vis. 2024 Jan 2;24(1):3. doi: 10.1167/jov.24.1.3.
PubMed 38190145Peyrin C, Roux-Sibilon A, Trouilloud A, Khazaz S, Joly M, Pichat C, Boucart M, Krainik A, Kauffmann L. Semantic and Physical Properties of Peripheral Vision Are Used for Scene Categorization in Central Vision. J Cogn Neurosci. 2021 Apr 1;33(5):799-813. doi: 10.1162/jocn_a_01689.
PubMed 34449843Trouilloud A, Kauffmann L, Roux-Sibilon A, Rossel P, Boucart M, Mermillod M, Peyrin C. Rapid scene categorization: From coarse peripheral vision to fine central vision. Vision Res. 2020 May;170:60-72. doi: 10.1016/j.visres.2020.02.008. Epub 2020 Apr 4.
PubMed 32259648Roux-Sibilon A, Peyrin C, Greenwood JA, Goffaux V. Radial bias in face identification. Proc Biol Sci. 2023 Jun 28;290(2001):20231118. doi: 10.1098/rspb.2023.1118. Epub 2023 Jun 28.
PubMed 37357864
Study at a glance
From the registry record, last updated by the sponsor on 27 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- RePer-AGE: Reorganization of Visuo-cognitive Functions Based on Peripheral Vision With Aging
- ClinicalTrials.gov ID
- NCT07727369
- Acronym / sponsor ID
- RePer-AGE / 38RC25.0395
- Conditions
- Aging, Visual Perception, Cognition
- Keywords
- Healthy Aging, Peripheral vision, Central vision, Visual recognition, Predictive processing, Psychophysics, Retinal sensitivity, fMRI
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 160 participants (estimated)
- Lead sponsor
- University Hospital, GrenobleUniversity, hospital or other
- Collaborators
- Centre National de la Recherche Scientifique, France, University Grenoble Alps, National Research Agency, France
- Study start
- 1 Sep 2026 (estimated)
- Primary completion
- Mar 2030 (estimated)
- Study completion
- Sep 2030 (estimated)
- First posted
- 27 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The RePer-AGE study investigates how central and peripheral vision contribute to visual recognition and how these mechanisms change with normal aging. The study is based on the hypothesis that peripheral vision provides rapid global information that supports visual recognition through predictive mechanisms. Healthy young adults (18-30 years) and older adults (60-85 years) will undergo visual psychophysical testing, ophthalmological examinations, and, for a subset of participants, functional magnetic resonance imaging (fMRI). The results are expected to improve our understanding of age-related changes in visuo-cognitive functions and provide reference data for future studies on age-related visual disorders.
Detailed description
Visual recognition depends on the complementary contribution of central and peripheral vision. Central vision provides high spatial resolution and supports the detailed analysis required for object identification, whereas peripheral vision rapidly extracts coarse visual information that provides a global representation of the surrounding environment. According to predictive models of visual processing, this early peripheral information is used to generate predictions that facilitate the subsequent processing of detailed visual inputs.
The RePer-AGE project is based on the hypothesis that peripheral vision plays a key role in predictive visual processing and that this contribution changes during normal aging. Although aging is associated with well-documented declines in visual acuity and contrast sensitivity, particularly for high spatial frequencies, several findings suggest that the processing of coarse visual information conveyed by peripheral vision may be relatively preserved. This preserved processing may contribute to compensatory mechanisms supporting visual recognition in older adults.
RePer-AGE is a prospective, monocentric interventional study conducted at Grenoble Alpes University Hospital (CHU Grenoble Alpes) and the Laboratoire de Psychologie et NeuroCognition (LPNC, CNRS, Université Grenoble Alpes). The study will recruit 160 healthy volunteers divided into two age groups: young adults (18-30 years) and older adults (60-85 years). Participants will undergo an ophthalmological examination to ensure normal or corrected-to-normal vision and the absence of ocular disease likely to affect visual performance. Older participants will also complete a brief cognitive screening assessment.
The project combines complementary behavioral, ophthalmological, and neuroimaging approaches to investigate the respective contributions of central and peripheral vision to visual recognition.
The first research axis combines psychophysical experiments with ophthalmological assessments. Participants perform computerized visual recognition tasks specifically designed to evaluate the relative contribution of central and peripheral vision. Additional ophthalmological examinations include automated static perimetry to assess retinal sensitivity across the visual field and low-luminance visual acuity testing. These measurements will allow the relationship between retinal function and visual recognition performance to be investigated.
The second research axis combines psychophysical experiments with functional magnetic resonance imaging (fMRI). During MRI acquisition, participants perform visual recognition tasks while blood oxygen level-dependent (BOLD) activity is recorded. These data will be used to identify the cortical networks supporting predictive visual processing and to determine how these neural mechanisms are modified during normal aging.
The psychophysical paradigms are derived from previous studies conducted by the research team and investigate two complementary aspects of visual recognition. One paradigm evaluates the respective contribution of central and peripheral vision to scene categorization, whereas the second examines how semantic information extracted from peripheral vision influences the recognition of centrally presented visual stimuli through predictive mechanisms.
The primary objective of the study is to determine how central and peripheral vision differentially contribute to visual recognition and how these mechanisms are reorganized with aging. Secondary objectives include characterizing age-related changes in retinal sensitivity, examining the relationship between retinal function and behavioral performance, and identifying the neural correlates of predictive visual processing using functional MRI.
The results of RePer-AGE are expected to improve the understanding of the mechanisms underlying normal visual aging. They will provide normative reference data for future studies investigating pathological aging and visual disorders affecting central vision, and may ultimately contribute to the development of new approaches for visual assessment and rehabilitation.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Participants are assigned to one of two experimental arms according to the study procedures (psychophysics with ophthalmology or psychophysics with functional MRI). Both young and older adults are included in each arm.
| Arm | Type | Receives |
|---|---|---|
| Psychophysics and Ophthalmology | Experimental | Behavioral: Psychophysical visual recognition tasks, Diagnostic Test: Ophthalmological assessmentParticipants undergo psychophysical visual recognition tasks together with ophthalmological examinations, including retinal sensitivity assessment by automated perimetry and low-luminance visual acuity testing. |
| Psychophysics and Functional MRI | Experimental | Behavioral: Psychophysical visual recognition tasks, Diagnostic Test: Functional magnetic resonance imaging (fMRI)Participants undergo psychophysical visual recognition tasks while functional magnetic resonance imaging (fMRI) is performed to investigate the neural mechanisms underlying visual recognition and predictive processing. |
Who may qualify
- Ages
- 18 to 85 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (12 listed)
- Healthy young adults aged 18 to 30 years or healthy older adults aged 60 to 85 years.
- Normal or corrected-to-normal visual acuity.
- No ophthalmological disease affecting visual function.
- For participants aged 60 years or older: Mini-Mental State Examination (MMSE) score ≥23.
- Affiliated with a national health insurance system.
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Psychophysical visual recognition tasksComputerized visual recognition tasks assessing the respective contributions of central and peripheral vision to scene recognition and predictive visual processing. | Behavioural | Psychophysics and Functional MRI, Psychophysics and Ophthalmology |
| Ophthalmological assessmentOphthalmological examinations including retinal sensitivity (Humphrey automated perimetry) and low-luminance visual acuity. | Diagnostic test | Psychophysics and Ophthalmology |
| Functional magnetic resonance imaging (fMRI)Functional MRI performed during psychophysical visual recognition tasks to assess brain activity associated with visual recognition and predictive visual processing. | Diagnostic test | Psychophysics and Functional MRI |
Primary outcome
Behavioral performance during scene categorization tasks
Time frame: Baseline (single experimental session)
Behavioral performance will be assessed using accuracy and response time during computerized scene categorization tasks evaluating (1) central versus peripheral vision (EXC paradigm) and (2) semantic congruency between peripheral and central vision (VPC paradigm). Comparisons will be performed between young and older adults.
2 secondary outcomes
Retinal sensitivity
Time frame: Baseline
Brain activation during visual recognition
Time frame: Baseline
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Jul 2026.
- Background: PubMed 38190145Faurite C, Aprile E, Kauffmann L, Mermillod M, Gallice M, Chiquet C, Cottereau BR, Peyrin C. Interaction between central and peripheral vision: Influence of distance and spatial frequencies. J Vis. 2024 Jan 2;24(1):3. doi: 10.1167/jov.24.1.3.
- Background: PubMed 34449843Peyrin C, Roux-Sibilon A, Trouilloud A, Khazaz S, Joly M, Pichat C, Boucart M, Krainik A, Kauffmann L. Semantic and Physical Properties of Peripheral Vision Are Used for Scene Categorization in Central Vision. J Cogn Neurosci. 2021 Apr 1;33(5):799-813. doi: 10.1162/jocn_a_01689.
- Background: PubMed 32259648Trouilloud A, Kauffmann L, Roux-Sibilon A, Rossel P, Boucart M, Mermillod M, Peyrin C. Rapid scene categorization: From coarse peripheral vision to fine central vision. Vision Res. 2020 May;170:60-72. doi: 10.1016/j.visres.2020.02.008. Epub 2020 Apr 4.
- Background: PubMed 37357864Roux-Sibilon A, Peyrin C, Greenwood JA, Goffaux V. Radial bias in face identification. Proc Biol Sci. 2023 Jun 28;290(2001):20231118. doi: 10.1098/rspb.2023.1118. Epub 2023 Jun 28.
- Individual participant dataSharing planned: Yes. De-identified individual participant data necessary to reproduce the results reported in scientific publications will be shared. Data may include demographic, behavioral, ophthalmological, and neuroimaging data after anonymization, in accordance with the study Data Management Plan and applicable data protection regulations.
Related trials for Aging
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
RecruitingPhase 2
Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)
Multiple Sclerosis
Not yet recruitingPhase 2
Validation & Intervention Testing for Aging, Longevity and Healthspan
Aging, Functional Decline
RecruitingObservational study
Effects of Obesity on Physical Abilities and Daily Living Activities in Elderly Adults
Obesity, Sarcopenic Obesity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Psychophysical visual recognition tasks, Ophthalmological assessment and Functional magnetic resonance imaging (fMRI) in people with Aging and Visual Perception, run by University Hospital, Grenoble at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 12 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 27 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Carole Peyrin, PhD (0033615351350, carole.peyrin@univ-grenoble-alpes.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Behavioral performance during scene categorization tasks (time frame: Baseline (single experimental session)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07727369, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jul 2026.